Cargando…
Genomic profiling for non-small cell lung cancer: Clinical relevance in staging and prognosis
Lung cancer is one of the most common cancers prevalent and around 80% of all cases are non-small cell lung cancer (NSCLC). Due to high recurrence rates, the mortality of NSCLC is high. Conventional staging systems allowed risk classification of patients in order to simplify the patient selection fo...
Autores principales: | Bhattarai, Abhinav, Shah, Sangam, Abu Serhan, Hashem, Sah, Ranjit, Sah, Sanjit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681555/ https://www.ncbi.nlm.nih.gov/pubmed/38013359 http://dx.doi.org/10.1097/MD.0000000000036003 |
Ejemplares similares
-
Systematic Endobronchial Ultrasound-guided Mediastinal Staging Versus Positron Emission Tomography for Comprehensive Mediastinal Staging in NSCLC Before Radical Radiotherapy of Non-small Cell Lung Cancer: A Pilot Study
por: Steinfort, Daniel P., et al.
Publicado: (2016) -
Effect of Preexisting Asthma on the Risk of ICU Admission, Intubation, and Death from COVID-19: A Systematic Review and Meta-Analysis
por: Bhattarai, Abhinav, et al.
Publicado: (2022) -
High expression of CD8 predicts favorable prognosis in patients with lung adenocarcinoma: A cohort study
por: Ye, Sheng-Lan, et al.
Publicado: (2017) -
Defining prognosis in sarcoidosis
por: Lopes, Mariana Carneiro, et al.
Publicado: (2020) -
Pre-existing Pulmonary Diseases and Survival in Patients With Stage-dependent Lung Adenocarcinoma: A STROBE-compliant Article
por: Jian, Zhi-Hong, et al.
Publicado: (2016)